The Thesis
US markets pulled back from records overnight as crude rebounded off midweek lows on softer Iran-deal optimism, and GIFT Nifty points to a gap-down open. Against that backdrop, today’s book leans hard into domestic-defensive pharma and selective capex/commodity beneficiaries – themes that decouple from FII outflow pressure as DII absorption stays intact. With VIX still sub-17, the stance is conviction-led, not risk-off.
Where We’re Concentrated
A five-stock pharma cluster (biosimilars, formulations, diagnostics) anchors defensiveness; a parallel capex axis spans defence, electricals, and airport infrastructure; commodity-linked names round out the book against the crude rebound. The thesis breaks if FII selling outpaces DII absorption and Nifty loses 24,000 – at that point pharma’s relative-value cushion compresses and the capex names re-correlate with risk-off flow.
Conviction Picks
Highest Conviction
GMR Airports
Breadth across momentum, swing and options confirms institutional positioning on India’s airport-capex cycle – a domestic theme insulated from overnight global wobble.
UPL
Agrichem leverage to a normal-monsoon setup; pricing power offsets the input-cost drag from this morning’s crude rebound.
Defensive Anchor
Biocon
Biosimilars pipeline keeps earnings visibility decoupled from FII flow – the kind of name that holds when Nifty wobbles intraday.
Hindustan Aeronautics
Multi-year defence-capex visibility; momentum signals confirm sustained accumulation while VIX stays contained.
Vedanta
Metals and oil mix benefits directly from the overnight crude rebound; dividend yield cushions any FII-driven drag on the broader tape.
One Thing to Watch
Nifty 50 must hold 24,250 on the gap-down open. A clean break invalidates the book’s defensive premise as broad-market correlation rises and pharma’s relative-value cushion compresses.